1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
2018) In Clinical cancer research : an official journal of the American Association for Cancer Research 24(23). p.5895-5901(
- Contribution to journal › Article
- 2015
-
Mark
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
(
- Contribution to journal › Article
- 2014
-
Mark
The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
(
- Contribution to journal › Article
- 2013
-
Mark
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.
(
- Contribution to journal › Article
-
Mark
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
(
- Contribution to journal › Article
- 2010
-
Mark
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
(
- Contribution to journal › Article
- 2009
-
Mark
Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer.
2009) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18. p.2501-2506(
- Contribution to journal › Article